Page last updated: 2024-09-04

2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman and Cardiovascular Diseases

2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman has been researched along with Cardiovascular Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frank, J; George, TW; Lodge, JK; Minihane, AM; Rimbach, G; Rodriguez-Mateos, AM; Spencer, JP1
Ames, BN; Christen, S; Jiang, Q; Shigenaga, MK1

Reviews

1 review(s) available for 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman and Cardiovascular Diseases

ArticleYear
gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention.
    The American journal of clinical nutrition, 2001, Volume: 74, Issue:6

    Topics: Aging; alpha-Tocopherol; Animals; Antioxidants; Biological Availability; Cardiovascular Diseases; Chromans; gamma-Tocopherol; Humans; Intestinal Absorption; Neoplasms; Nutritive Value; Propionates; Prostaglandin-Endoperoxide Synthases; Vitamin E Deficiency

2001

Trials

1 trial(s) available for 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman and Cardiovascular Diseases

ArticleYear
Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men.
    The Journal of nutrition, 2009, Volume: 139, Issue:1

    Topics: Adolescent; Adult; Biomarkers; Camellia sinensis; Cardiovascular Diseases; Catechin; Chromans; Creatinine; Double-Blind Method; Humans; Liver; Male; Middle Aged; Plant Extracts; Propionates

2009